Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States

被引:7
|
作者
Wadsworth, Elle [1 ]
Hines, Lindsey A. [2 ,3 ]
Hammond, David [1 ]
机构
[1] Univ Waterloo, Sch Publ Hlth Sci, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada
[2] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England
[3] Univ Bristol, Bristol Med Sch, Integrat Epidemiol Unit, Bristol, Avon, England
基金
英国惠康基金; 加拿大健康研究院;
关键词
Opioids; pain; cannabis; marijuana; legalization; substitution; MARIJUANA; LEGALIZATION; DEATHS; LAWS;
D O I
10.1080/08897077.2022.2060431
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims: With increased liberalization of cannabis policies in North America, there is growing interest in the use of cannabis to manage pain instead of opioids. The objectives of the study were to (1) examine the use of cannabis for pain relief in Canada and the United States (US) in 2018 and 2019; (2) examine the association between recreational cannabis laws and changes in the use of cannabis for pain relief, instead of opioids or prescription pain medication. Methods: Repeat cross-sectional survey data were used from Wave 1 and Wave 2 of the International Cannabis Policy Study conducted in 2018 and 2019 in Canada and the US. Respondents were recruited through commercial panels, aged 16-65, and had ever tried cannabis (N = 44,119). Weighted binary logistic regression models examined the association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication (n = 15,092). Results: Between 14-33% of cannabis consumers in Canada and the US reported using cannabis to manage headaches or pain. Of these consumers, 79% and 78% respondents in Canada; 80% and 83% in US illegal states; and 83% and 84% in US legal states, in 2018 and 2019, respectively, reported cannabis use for pain relief instead of opioids or prescription pain medication. There was little evidence of an association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication, among Canadian (AOR = 0.98, 95% CI: 0.78, 1.22) and US respondents (AOR = 1.11, 95% CI: 0.96, 1.28). Conclusions: Although substitution of cannabis for opioids or prescription pain medication is common among those who use cannabis for pain, there does not seem to be a significant difference according to cannabis legality. Future research should examine cannabis and opioid substitution using different research designs and time frames.
引用
收藏
页码:943 / 948
页数:6
相关论文
共 50 条
  • [1] Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States
    Wadsworth, Elle
    Goodman, Samantha
    Hammond, David
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 2023, 55 (04) : 483 - 492
  • [2] Self-reported cannabis expenditure in the USA and Canada by daily and nondaily cannabis users
    Lim, Carmen C. W.
    Leung, Janni
    Stjepanovic, Daniel
    Hall, Wayne
    Connor, Jason
    Gartner, Coral
    Wadsworth, Elle
    Hammond, David
    Chan, Gary C. K.
    [J]. DRUG AND ALCOHOL REVIEW, 2022, 41 : S88 - S89
  • [3] Prevalence and factors associated with self-reported exposure to secondhand cannabis smoke in the United States and Canada in 2019
    Driezen, Pete
    Kaufman, Pamela
    Chaiton, Michael
    Goodman, Samantha
    Hammond, David
    [J]. PREVENTIVE MEDICINE, 2022, 157
  • [4] Changes in self-reported cannabis use in the United States from 1979 to 2022
    Caulkins, Jonathan P.
    [J]. ADDICTION, 2024, 119 (09) : 1648 - 1652
  • [5] Self-reported cannabis use and biomarkers of inflammation among adults in the United States
    Okafor, Chukwuemeka N.
    Li, Michael
    Paltzer, Jason
    [J]. BRAIN, BEHAVIOR, & IMMUNITY - HEALTH, 2020, 7
  • [6] A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada
    Antoine Asselin
    Olivier Beauparlant Lamarre
    Richard Chamberland
    Sarah-Jeanne McNeil
    Eric Demers
    Arsène Zongo
    [J]. Journal of Cannabis Research, 4
  • [7] A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada
    Asselin, Antoine
    Lamarre, Olivier Beauparlant
    Chamberland, Richard
    Mcneil, Sarah-Jeanne
    Demers, Eric
    Zongo, Arsene
    [J]. JOURNAL OF CANNABIS RESEARCH, 2022, 4 (01)
  • [8] A study of self-reported personal cannabis use and state legal status and associations with engagement in and perceptions of cannabis-impaired driving
    Brown, Timothy
    Banz, Barbara
    Schmitt, Rose
    Gaffney, Gary
    Milavetz, Gary
    Camenga, Deepa
    Li, Kaigang
    Brooks-Russell, Ashley
    Vaca, Federico
    [J]. TRAFFIC INJURY PREVENTION, 2022, 23 : S183 - S186
  • [9] Self-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United States
    Volkow, Nora D.
    Han, Beth
    Compton, Wilson M.
    McCance-Katz, Elinore F.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (02): : 167 - 169
  • [10] Self-Reported Effectiveness of Cannabis for Arthritis-Related Pain
    Wipfler, Kristin
    Zeiger, Joanna
    Michaud, Kaleb
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2349 - 2352